For the end of February, France was only using about a quarter of its AstraZeneca doses, compared with 82% for vaccines made by Pfizer Biontech and 37% for the Modern, a shot partly due to logistical bottlenecks but also because some French people don't trust the AstraZeneca shot.
就2月底而言,法國只使用了大約四分之一的阿斯利康劑量,而輝瑞Biontech公司生產的疫苗使用量為82%,Modern的使用量為37%,這種注射方式部分是由於物流瓶頸,但也因為一些法國人不信任阿斯利康的注射方式。